Retatrutide (RETA, LY3437943) is an investigational triple incretin receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors to suppress appetite, enhance insulin secretion, promote energy expenditure, and improve metabolic function, primarily for treating obesity and type 2 diabetes.
Original price was: $280.00.$250.00Current price is: $250.00.
We deliver peptides with the highest standards of purity and consistency, verified through advanced testing methods to ensure safe and reliable research outcomes.
With trusted shipping partners, your order is processed quickly and delivered securely, ensuring your products arrive on time and in perfect condition.
Backed by thousands of satisfied customers worldwide, our peptides are the go-to choice for researchers who value precision, reliability, and results.
